Kopran Share Price increased almost 7% in Trade Today

Kopran is the group company of Parijat Enterprises and is currently an integrated Pharmaceutical Company manufacturing a large range of products. It manufactures both Active Pharmaceutical Ingredients (API) and Finished Dosage Forms. Kopran’s products are listed globally and its facilities are in line with best of international standards and are approved by various Regulatory authorities. Kopran is focused on improvement in technology and new products accordingly integrated through their sophisticated Research & Development department.

Today, Kopran share price increased almost 7 per cent intraday to trade at the intraday high of Rs. 55.60.

Kopran Ltd is in the Pharmaceuticals sector, having a market cap of Rs. 224.91 as on 9^th December 2016 crores. It has reported the consolidated sales of Rs. 76.88 crores and a net profit of Rs. 3.64 crores for the quarter ended September 2016. While it had posted the consolidated sales figure of Rs. 61.26 crores and the net profit of Rs. 2.10 crores in the June quarter.

At 11:48 AM, Kopran share price was trading at Rs. 54.60, up by 5 per cent as compared to the 0.26 per cent rise in the Benchmark Index Nifty. The stock had opened at Rs. 53.35 while it had closed at Rs. 52 in the previous trading session. So far approximately four lakh shares had changed hands over the NSE trading counter. Currently the stock is trading at its 50 DMA with the beta of 1.56.

The share of face value Rs. 10 has the book value of Rs. 23.15. The company has posted the EPS of 2.76 in the last financial year while in the September quarter it has the EPS of 0.25, higher than the 0.16 EPS of June quarter. Kopran is the top 500 stock as identified by Dynamic Levels for the quarter. For the details on the stock, visit Kopran share price history page of Dynamic Levels website.